Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Blood test may be superior to Ct scans in predicting survival in some ovarian cancer patients

13.09.2004


Test may allow patients to avoid costly and time-consuming CT scans



A new study shows that the CA125 blood test, which measures the level of protein produced by ovarian cancer cells in the blood, may be superior to standard imaging techniques like CT scans in predicting survival in patients with recurrent ovarian cancer. The study, to be published online September 13 in the Journal of Clinical Oncology, is the first to compare the two procedures with respect to survival.

"This is good news for patients – our study indicates that selected patients can be safely monitored by blood tests alone and thus avoid costly and time consuming CT scans," said Bo Gronlund, MD, lead author and head of the CODOVA database at the Department of Oncology at Rigshospitalet, the Copenhagen University Hospital.


CT scans and other imaging techniques are often used in patients with recurrent cancer to assess whether the patient is responding to treatment. RECIST, the standard criteria for analyzing CT scans and ultrasonography, assesses treatment response by measuring the growth or shrinkage of the tumor.

However, unlike other solid tumors, ovarian cancer spreads diffusely through the abdomen, making tumor tissue much more difficult to detect through CT scans. As a result, response cannot always be measured by RECIST criteria.

Researchers hypothesized that the CA125 blood test might be a better tool for observing tumor growth among patients whose cancer has returned than traditional imaging techniques. To compare the two procedures, they used the RECIST criteria and a set of criteria for the CA125 blood test, which assesses treatment response according to the level of CA125 protein present in the blood.

Using one of the world’s largest database of patients with recurrent ovarian cancer, researchers retrospectively studied 131 patients receiving topotecan or paclitaxel-carboplatin as a second-line chemotherapy. Researchers found that the CA125 criteria were 2.6 times more accurate than RECIST in predicting survival, and concluded that in selected patients, tumor-marker guided response criteria like CA125 may be superior to imaging-based response criteria in predicting the outcome of second-line chemotherapy.

However, researchers noted that the study findings are only applicable to patients treated with topecan or paclitaxel-carboplatin, and pointed to the need for a randomized trial that includes additional chemotherapy agents or novel targeted therapies and that assesses CA125 and RECIST criteria in predicting both survival and quality of life.

An accompanying editorial by Professor Gordon J.S. Rustin of Mount Vernon Cancer Centre in Middlesex, UK underscored the importance of determining which response criteria is the more reliable method for predicting survival and clinical benefit.

"The CA125 response criteria has great potential value in clinical trials. Increased confidence in a CA125 response definition should lead to a cheaper, and in some cases, more accurate method for monitoring ovarian cancer therapy than standard radiographic criteria," he said.

Carrie Housman | EurekAlert!
Further information:
http://www.asco.org

More articles from Studies and Analyses:

nachricht New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg

nachricht Disarray in the brain
18.12.2017 | Universität zu Lübeck

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Thanks for the memory: NIST takes a deep look at memristors

22.01.2018 | Materials Sciences

Radioactivity from oil and gas wastewater persists in Pennsylvania stream sediments

22.01.2018 | Earth Sciences

Saarland University bioinformaticians compute gene sequences inherited from each parent

22.01.2018 | Life Sciences

VideoLinks Wissenschaft & Forschung
Overview of more VideoLinks >>>